Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence.
Cancer Res. 2006 Mar 15;66(6):3106-13. doi: 10.1158/0008-5472.CAN-05-3702.
Cancer Res. 2006.
PMID: 16540660
Prostaglandin F(2alpha) stimulates motility and invasion in colorectal tumor cells.
Qualtrough D, Kaidi A, Chell S, Jabbour HN, Williams AC, Paraskeva C.
Qualtrough D, et al.
Int J Cancer. 2007 Aug 15;121(4):734-40. doi: 10.1002/ijc.22755.
Int J Cancer. 2007.
PMID: 17437271
Free PMC article.
Item in Clipboard
Prospects in NSAID-derived chemoprevention of colorectal cancer.
Chell S, Patsos HA, Qualtrough D, H-Zadeh AM, Hicks DJ, Kaidi A, Witherden IR, Williams AC, Paraskeva C.
Chell S, et al.
Biochem Soc Trans. 2005 Aug;33(Pt 4):667-71. doi: 10.1042/BST0330667.
Biochem Soc Trans. 2005.
PMID: 16042570
Review.
Item in Clipboard
Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer.
Chell S, Kaidi A, Williams AC, Paraskeva C.
Chell S, et al.
Biochim Biophys Acta. 2006 Aug;1766(1):104-19. doi: 10.1016/j.bbcan.2006.05.002. Epub 2006 May 23.
Biochim Biophys Acta. 2006.
PMID: 16859832
Review.
Item in Clipboard
Inhibition of COX-2 with NS-398 decreases colon cancer cell motility through blocking epidermal growth factor receptor transactivation: possibilities for combination therapy.
Banu N, Buda A, Chell S, Elder D, Moorghen M, Paraskeva C, Qualtrough D, Pignatelli M.
Banu N, et al.
Cell Prolif. 2007 Oct;40(5):768-79. doi: 10.1111/j.1365-2184.2007.00459.x.
Cell Prolif. 2007.
PMID: 17877615
Free PMC article.
Item in Clipboard
Colorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM.
Wickenden JA, Jin H, Johnson M, Gillings AS, Newson C, Austin M, Chell SD, Balmanno K, Pritchard CA, Cook SJ.
Wickenden JA, et al. Among authors: chell sd.
Oncogene. 2008 Dec 4;27(57):7150-61. doi: 10.1038/onc.2008.335. Epub 2008 Sep 22.
Oncogene. 2008.
PMID: 18806830
Free PMC article.
Item in Clipboard
Intrinsic resistance to the MEK1/2 inhibitor AZD6244 (ARRY-142886) is associated with weak ERK1/2 signalling and/or strong PI3K signalling in colorectal cancer cell lines.
Balmanno K, Chell SD, Gillings AS, Hayat S, Cook SJ.
Balmanno K, et al. Among authors: chell sd.
Int J Cancer. 2009 Nov 15;125(10):2332-41. doi: 10.1002/ijc.24604.
Int J Cancer. 2009.
PMID: 19637312
Free article.
Item in Clipboard
Cite
Cite